US-based West Pharmaceutical Services’ indirect subsidiary, West Pharmaceutical India Packaging, has begun the construction of its new compression moulding facility located in Sri City, India.
The plant, which will be part of West’s global supply chain, will manufacture pharmaceutical packaging components.
According to West, phase one construction comprising a built-up area of 15,300m² will begin in August 2012 on a metal seal assembly and compression moulding facility.
The facility will produce metal and elastomeric pharmaceutical components that are used in primary packaging of injectable medicines manufactured by the company’s pharmaceutical and biopharmaceutical customers in India and the wider Asia Pacific region.
Commercial production of metal components is expected to begin in the first quarter of 2014, while production of a range of standard elastomeric components will start in the first quarter of 2015.
Warwick Bedwell, West Pharmaceutical Packaging Systems Asia Pacific Region president, said the latest investment will enable the company to partner with customers in India and the Asia Pacific region and help them provide medicines to patients safely.
"When the facility is completed, we anticipate a reduction in lead times for supply to our customers in India. By leveraging our global sourcing activities and process engineering expertise, we will be able to carefully manage the overall costs of production," Bedwell added.
Phase 3 of the construction will be completed in 2023, when the built-up area for West’s proposed plant and office would reach 37,700m².
In June 2012, West signed a 99-year lease on 72,800m² of land in the Sri City Special Economic Zone (SEZ), located along the border of Andhra Pradesh and Tamil Nadu states of India.